Sylvant Interactions
There are 316 drugs known to interact with Sylvant (siltuximab), along with 4 disease interactions. Of the total drug interactions, 46 are major, 261 are moderate, and 9 are minor.
- View all 316 medications that may interact with Sylvant
- View Sylvant disease interactions (4)
Most frequently checked interactions
View interaction reports for Sylvant (siltuximab) and the medicines listed below.
- Actemra (tocilizumab)
- Alprolix (coagulation factor ix)
- Amevive (alefacept)
- Amicar (aminocaproic acid)
- AquADEKs (multivitamin with minerals)
- Aralast NP (alpha 1-proteinase inhibitor)
- Aranesp (darbepoetin alfa)
- Austedo (deutetrabenazine)
- Baraclude (entecavir)
- Berinert (C1 esterase inhibitor (human))
- Biaxin (clarithromycin)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Butisol Sodium (butabarbital)
- Bydureon (exenatide)
- Calquence (acalabrutinib)
- Caprelsa (vandetanib)
- Carimune NF (immune globulin intravenous)
- Complera (emtricitabine / rilpivirine / tenofovir disoproxil)
- Cosentyx (secukinumab)
- Cotellic (cobimetinib)
- Creon (pancrelipase)
- Crysvita (burosumab)
- Cytovene (ganciclovir)
- Cytoxan Lyophilized (cyclophosphamide)
- Detrol LA (tolterodine)
- Diacomit (stiripentol)
- Jynarque (tolvaptan)
- Kalydeco (ivacaftor)
- Xadago (safinamide)
Sylvant disease interactions
There are 4 disease interactions with Sylvant (siltuximab) which include:
Report options
More about Sylvant (siltuximab)
- Sylvant consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Adbry
Adbry is used to treat moderate-to-severe atopic dermatitis (eczema) in adults and children aged 12 ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Arcalyst
Arcalyst (rilonacept) is used to treat Cryopyrin-Associated Periodic Syndromes, Deficiency of ...
Bimzelx
Bimzelx (bimekizumab) treats plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and ...
Cinqair
Cinqair (reslizumab) is a monoclonal antibody that affects the actions of the body's immune system ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Ebglyss
Ebglyss (lebrikizumab) is a treatment for moderate-to-severe atopic dermatitis given as a monthly ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.